Blueshift Asset Management »

Axsome Therapeutics shares owned by Blueshift Asset Management

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Blueshift Asset Management from 13F filings

Historical chart of Blueshift Asset Management investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Blueshift Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Blueshift Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $304k 1.8k 169.02
2023-03-31 $232k 3.8k 61.68
2022-09-30 $216k 4.8k 44.68
2019-06-30 $812k 32k 25.74

More positions owned by Blueshift Asset Management

Ishares Tr Russell 2000 Etf (IWM)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Etsy (ETSY)
Avis Budget (CAR)
Match Group (MTCH)
O'reilly Automotive (ORLY)
Five Below (FIVE)
Murphy Usa (MUSA)
Equifax (EFX)
CarMax (KMX)
Nike CL B (NKE)
Walt Disney Company (DIS)
Affirm Hldgs Com Cl A (AFRM)
Target Corporation (TGT)
Royal Caribbean Cruises (RCL)

View all positions for Blueshift Asset Management

Top funds holding Axsome Therapeutics

BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
FMR
Invesco
Geode Capital Management
Wellington Management Company
Deep Track Capital
State Street Corporation
Nomura Asset Management International
Adage Capital Partners GP
Alethea Capital Management
D. E. Shaw & Co
Bank of America Corporation
First Trust Advisors

View all funds holding Axsome Therapeutics